Strategic Program Cancer nieuws
Strategic Program Cancer nieuws
New, innovative breast cancer research
How can AI help pathologists find metastases in breast cancer faster (and in an less expensive way)? And why are breast cancer tumors more likely to be more aggressive in pregnant women? Two new innovative studies from UMC Utrecht evolve around these questions. Researchers present the results today at the leading San Antonio Breast Cancer Symposium.
Read moreTackling cancer: healthy lifestyle and yoga
Do healthy lifestyle habits help prevent neuroendocrine tumors? Does yoga reduce the side effects of hormone therapy in women with breast cancer? Researchers at UMC Utrecht are addressing these questions in two new studies, for which they have received grants from the World Cancer Research Fund.
Read morePay attention to late effects of childhood cancer
Leontien Kremer, professor of late effects after childhood cancer at Utrecht University delivered her oration titled 'LIFE: now and LATER' on caring for survivors of childhood cancer with late effects, health problems after treatment.
Read moreESMO revisited
The ESMO Congress 2023 has concluded successfully. The global oncology community gathered in Spain to showcase the latest innovative oncology research and treatments. Our researchers from UMC Utrecht showed their robust contribution to cancer research, with presentations ranging from novel therapeutic combinations to new ways to track symptoms.
Read moreAI speeds up identification brain tumor type
What type of brain tumor does this patient have? AI technology helps to determine this as early as during surgery, within 1.5 hours. This process normally takes a week. The new technology allows neurosurgeons to adjust their surgical strategies on the spot. Today, researchers from UMC Utrecht and researchers, pathologists and neurosurgeons from the Princess Máxima Center for pediatric oncology and Amsterdam UMC have published about this study in Nature.
Read moreNew partnership accelerates the development of new cancer therapies
Cancer is one of the greatest health challenges of our time. We still do not succeed in providing effective treatment to all cancer patients. Oncode Accelerator now aims to change this. Within this partnership, more than 30 public and private partners, including UMC Utrecht, are now working together. Its aim: to make patients benefit from effective therapies faster.
Read moreHow do immune cells recognise cancer?
UMC Utrecht unravels how immune cells recognise and battle cancer.
Read moreAI foresees higher risk of breast cancer
Women with dense breast tissue are more likely to develop breast cancer. With the help of AI (artificial intelligence), researchers from UMC Utrecht have now found a factor that may be an additional indicator that cancer is developing within dense breasts: the extent to which the normal glandular tissue lights up on the MRI because of the contrast fluid. This result may ultimately help to more effectively use additional MRI scans to detect cancer in dense breast tissue.
Read moreMarcel Kool appointed Professor of Childhood brain tumors
Prof. dr. Marcel Kool has been appointed professor of Childhood brain tumors at UMC Utrecht. With his professorship, he aims to accelerate developments in precision medicine: 'Together we can ensure that knowledge from the lab is translated more quickly into clinical studies for the children who stand to benefit the most.'
Read moreLeendert Looijenga becomes professor
Leendert Looijenga has been appointed professor of translational germ cell oncology and fertility at UMC Utrecht. With his chair, he aims to improve the diagnosis and follow-up of children and young adults with germ cell tumours to contribute to improved survival and quality of life.
Read more